KR880000086A - 카비도파/레보도파의 서방성 혼합제제 - Google Patents
카비도파/레보도파의 서방성 혼합제제 Download PDFInfo
- Publication number
- KR880000086A KR880000086A KR1019870006037A KR870006037A KR880000086A KR 880000086 A KR880000086 A KR 880000086A KR 1019870006037 A KR1019870006037 A KR 1019870006037A KR 870006037 A KR870006037 A KR 870006037A KR 880000086 A KR880000086 A KR 880000086A
- Authority
- KR
- South Korea
- Prior art keywords
- soluble polymer
- polymer
- formulation
- water soluble
- cellulose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1 도는 약제 성분이 균일하게 분산되어 있는 정제-형 균질 중합체 매트릭스 1의 횡단면도이다.
제 2 도는 약제 일부가 사행(蛇行)성 미공질 통로 2를 통해 확산되어 방출된후의 동일한 중합체 매트릭스의 개략도이다.
Claims (8)
- 수용성 중합체 0내지 120mg 및 난용성 중합체 0내지 120mg을 함유하는 중합체 비히클(단, 중합체 둘다가 0mg은 아니다)중의 카비도파 5내지 300mg, 레보다파 2내지 1200mg, 정제용 윤활제 0내지 25mg 및 임의의 약제학적으로 허용되는 염료의 균질분산액을 함유하며, 투여후에 제제로부터 카비도파와 레보도파가 동시에 서방출되도록 하는 경구투여용 서방성 제제.
- 제 1 항에 있어서, 중합체 비하클이 하이드록시프로필 셀룰로즈, 하이드록시 프로필메틸 셀룰로즈, 폴리비닐 피롤리론, 폴리에틸렌 글리콜, 전분 및 메틸셀룰로즈중에서 선택되는 수용성 중합체이거나, 폴리비닐 아세테이트 크로돈산 공중합체, 폴리비닐 클로라이드, 폴리에틸렌, 셀룰로즈 아세테이트, 폴리비닐 알코올, 에틸렌 비닐 아세테이트 공중합체, 폴리비닐 아세테이트, 폴리메틸 메타크릴레이트, 및 에틸셀룰로즈중에서 선택된 난용성 중합체이거나, 수용성 중합체와 난용성 중합체의 혼합물인 제제.
- 제 2 항에 있어서, 중합체 비히클이 수용성 중합체와 난용성중합체의 혼합물인 제제.
- 제 3 항에 있어서, 수용성 중합체가 하이드로 프로필 셀룰로즈이고 난용성 중합체는 폴리비닐 아세테이트-크로톤산 공중합체인 제제.
- 제 1 항에 있어서, 수용성 중합체 5내지 25mg 및 난용성 중합체 2내지 50mg을 함유하는 중합체 비히클중의 카비도파 25 내지 100mg, 레보도파 100 내지 400mg, 정체용 윤활제 1내지 10mg 및 임의의 약제학적으로 허용되는 염료의 균질분산액을 함유하며, 투여후에 제제로부터 카비도파 및 레보도파가 동시에 서서히 방출되도록 하는 경구투여용 서방성 제제.
- 제 5 항에 있어서, 중합체 비히클이 하이드록시 프로필 셀룰로즈, 하이드록시프로필메틸 셀룰로즈 폴리비닐 피롤리돈, 폴리에틸렌글리콜, 전분 및 에틸셀룰로즈중에서 선택된 수용성 중합체이거나, 폴리비닐아세테이트-크로톤산 공중합체, 폴리비닐 클로라이드, 폴리에틸렌, 셀룰로즈아세테이트, 폴리비닐 알코올, 에틸렌 비닐아세테이트 공중합체, 폴리비닐 아세테이트, 폴리메틸 메타크릴레이트, 및 에틸 셀룰로즈 중에서 선택된 난용성 중합체이거나, 수용성 중합체와 난용성 중합체의 혼합물인 제제.
- 제 6 항에 있어서, 중합체 비히클이 수용성 중합체와 난용성 중합체의 혼합물인 제제.
- 제 7 항에 있어서, 수용성 중합체가 하이드록시 프로필 셀룰로즈이고 난용성 중합체가 폴리비닐 아세테이트크로톤산 공중합체인 제제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87498886A | 1986-06-16 | 1986-06-16 | |
US874988 | 1986-06-16 | ||
US874,988 | 1986-06-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR880000086A true KR880000086A (ko) | 1988-03-23 |
KR950002882B1 KR950002882B1 (ko) | 1995-03-28 |
Family
ID=25365017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870006037A KR950002882B1 (ko) | 1986-06-16 | 1987-06-15 | 카비도파/레보도파의 서방성 경구 투여형 제제 |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0253490B1 (ko) |
JP (1) | JPS6354319A (ko) |
KR (1) | KR950002882B1 (ko) |
AT (1) | ATE58473T1 (ko) |
AU (1) | AU597670B2 (ko) |
CY (1) | CY1578A (ko) |
DE (1) | DE3766308D1 (ko) |
DK (1) | DK170514B1 (ko) |
ES (1) | ES2018548B3 (ko) |
GR (1) | GR3001102T3 (ko) |
HK (1) | HK56191A (ko) |
IE (1) | IE60508B1 (ko) |
IL (1) | IL82823A (ko) |
NZ (1) | NZ220599A (ko) |
PT (1) | PT85049B (ko) |
SG (1) | SG52191G (ko) |
ZA (1) | ZA874233B (ko) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4832957A (en) * | 1987-12-11 | 1989-05-23 | Merck & Co., Inc. | Controlled release combination of carbidopa/levodopa |
US4983400A (en) * | 1986-06-16 | 1991-01-08 | Merck & Co., Inc. | Controlled release combination of carbidopa/levodopa |
SE460947B (sv) * | 1986-08-26 | 1989-12-11 | Lejus Medical Ab | En multiple-unit-dos komposition av l-dopa |
US5095054A (en) * | 1988-02-03 | 1992-03-10 | Warner-Lambert Company | Polymer compositions containing destructurized starch |
IL94588A0 (en) * | 1989-06-22 | 1991-04-15 | Warner Lambert Co | Polymer base blend compositions containing destructurized starch |
CA2037178A1 (en) * | 1990-02-28 | 1991-08-29 | Albert Walter Brzeczko | Deprenyl/l-dopa/carbidopa pharmaceutical composition |
HU208495B (en) * | 1990-06-27 | 1993-11-29 | Alkaloida Vegyeszeti Gyar | Process for producing retarde pharmaceutical compositions |
DE4101873C2 (de) * | 1991-01-23 | 1993-12-09 | Isis Pharma Gmbh | Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände |
US5624960A (en) * | 1991-01-23 | 1997-04-29 | Isis Pharma Gmbh | Orally administrable drugs for the treatment of central dopamine deficiency conditions |
US5281420A (en) * | 1992-05-19 | 1994-01-25 | The Procter & Gamble Company | Solid dispersion compositions of tebufelone |
DE4341156C2 (de) * | 1993-12-02 | 1997-11-13 | Wacker Chemie Gmbh | Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger |
GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
CA2216215A1 (en) | 1997-04-05 | 1998-10-05 | Isa Odidi | Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity |
US5945424A (en) * | 1998-07-31 | 1999-08-31 | G & H Associates, Inc. | Treatment of periodic limb movement syndrome |
FI109453B (fi) | 1999-06-30 | 2002-08-15 | Orion Yhtymae Oyj | Farmaseuttinen koostumus |
US6531153B2 (en) * | 2001-05-29 | 2003-03-11 | Drugtech Corporation | Composition with sustained release of levodopa and carbidopa |
US6682759B2 (en) * | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
EP1946780B1 (en) | 2005-11-11 | 2012-01-11 | Asahi Kasei Chemicals Corporation | Controlled release solid preparation |
WO2007113371A1 (en) * | 2006-03-31 | 2007-10-11 | Iprbox Oy | Pharmaceutical composition and preparation method thereof |
KR101569604B1 (ko) | 2007-12-28 | 2015-11-16 | 임팩스 라보라토리즈, 인코포레이티드 | 레보도파 방출 제어형 제제 및 이의 용도 |
TR201204839A2 (tr) | 2012-04-25 | 2012-12-21 | Ali̇ Rai̇f İlaç Sanayi̇ A.Ş. | Uzatılmış salım sağlayan levodopa karbıdopa entakapon içeren tablet formülasyonu. |
IN2013MU01208A (ko) * | 2013-03-28 | 2015-07-03 | Omniactive Health Technologies Ltd | |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
EP3782614A1 (en) | 2013-10-07 | 2021-02-24 | Impax Laboratories, LLC | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
WO2015127558A1 (en) * | 2014-02-28 | 2015-09-03 | UNIVERSITé LAVAL | Methods and uses for inducing or facilitating micturition in a patient in need thereof |
JP7066351B2 (ja) * | 2017-08-18 | 2022-05-13 | 大原薬品工業株式会社 | 良好な徐放性を有する、レボドパ含有小型化錠剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH468192A (de) * | 1964-06-19 | 1969-02-15 | Ciba Geigy | Verfahren zur Herstellung von Arzneimitteln in Perlenform |
US3632739A (en) * | 1969-12-29 | 1972-01-04 | Sandoz Ag | Solid sustained release pharmaceutical preparation |
ATE20311T1 (de) * | 1981-07-08 | 1986-06-15 | Key Pharma | Polymerische diffusionsmatritze propranolol enthaltend. |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
-
1987
- 1987-06-08 NZ NZ220599A patent/NZ220599A/xx unknown
- 1987-06-09 DE DE8787305086T patent/DE3766308D1/de not_active Expired - Lifetime
- 1987-06-09 AT AT87305086T patent/ATE58473T1/de not_active IP Right Cessation
- 1987-06-09 ES ES87305086T patent/ES2018548B3/es not_active Expired - Lifetime
- 1987-06-09 IL IL82823A patent/IL82823A/xx not_active IP Right Cessation
- 1987-06-09 EP EP87305086A patent/EP0253490B1/en not_active Expired - Lifetime
- 1987-06-09 PT PT85049A patent/PT85049B/pt unknown
- 1987-06-12 IE IE155987A patent/IE60508B1/en not_active IP Right Cessation
- 1987-06-12 ZA ZA874233A patent/ZA874233B/xx unknown
- 1987-06-15 DK DK302587A patent/DK170514B1/da not_active IP Right Cessation
- 1987-06-15 KR KR1019870006037A patent/KR950002882B1/ko not_active IP Right Cessation
- 1987-06-15 AU AU74228/87A patent/AU597670B2/en not_active Expired
- 1987-06-16 JP JP62148147A patent/JPS6354319A/ja active Granted
-
1990
- 1990-11-23 GR GR90400929T patent/GR3001102T3/el unknown
-
1991
- 1991-07-02 SG SG52191A patent/SG52191G/en unknown
- 1991-07-18 HK HK561/91A patent/HK56191A/xx not_active IP Right Cessation
- 1991-12-20 CY CY1578A patent/CY1578A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0253490B1 (en) | 1990-11-22 |
AU597670B2 (en) | 1990-06-07 |
DK302587D0 (da) | 1987-06-15 |
GR3001102T3 (en) | 1992-05-12 |
SG52191G (en) | 1991-08-23 |
PT85049A (en) | 1987-07-01 |
DK302587A (da) | 1987-12-17 |
NZ220599A (en) | 1990-10-26 |
DE3766308D1 (de) | 1991-01-03 |
KR950002882B1 (ko) | 1995-03-28 |
IL82823A0 (en) | 1987-12-20 |
DK170514B1 (da) | 1995-10-09 |
EP0253490A1 (en) | 1988-01-20 |
CY1578A (en) | 1991-12-20 |
ATE58473T1 (de) | 1990-12-15 |
IE871559L (en) | 1987-12-16 |
PT85049B (pt) | 1990-03-08 |
IE60508B1 (en) | 1994-07-27 |
JPS6354319A (ja) | 1988-03-08 |
JPH0445B2 (ko) | 1992-01-06 |
IL82823A (en) | 1991-03-10 |
ES2018548B3 (es) | 1991-04-16 |
ZA874233B (en) | 1987-12-14 |
AU7422887A (en) | 1987-12-17 |
HK56191A (en) | 1991-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880000086A (ko) | 카비도파/레보도파의 서방성 혼합제제 | |
KR890009377A (ko) | 방출 조절된 카비도파/레보도파 배합물 | |
ES2173891T3 (es) | Sistema de liberacion pulsatil de un farmaco multiparticulado. | |
TR199800777T2 (xx) | Zay�f ��z�n�rl��e sahip bazik ila�lar i�in kontroll� salma form�lasyon. Zay�f ��z�n�rl��e sahip bazik ila�lar i�in kontroll� salma form�lasyonu. | |
KR950007841A (ko) | 트라마돌 염을 함유하는 서방성 약물 제제 | |
DE69100991D1 (de) | Pharmazeutische formulierungen. | |
DE69322077T2 (de) | Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe | |
ATE302597T1 (de) | Im magen verweilende orale dosierungsformen von wasserlöslichen arzneistoffen mit kontrollierter freisetzung | |
ES2001897A6 (es) | Procedimiento para la fabricacion de una tableta de liberacion controlada | |
KR880010759A (ko) | 방출 조절성 제제 | |
KR880002515A (ko) | 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물 | |
DE3852145D1 (de) | Indolderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten. | |
ATE76290T1 (de) | Galenische formen mit verzoegerter verapamilfreisetzung, deren herstellung und diese enthaltende arzneimittel. | |
KR870008594A (ko) | 베라파밀제형 | |
IT1153487B (it) | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli | |
EP0378137A3 (de) | Neue Arzneiform | |
Choulis et al. | Timed‐release tablets containing quinine sulfate | |
DE60032704T2 (de) | Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit | |
DK0483320T3 (da) | Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf | |
KR930019205A (ko) | 팽윤성 하이드로겔을 이용한 위내 체류형 장기 지속성 경구투여 정제의 제조방법 | |
Dollery | Chairman's Introduction | |
Daynes | Lowerlip syndrome-a form of lupus erythematosus | |
KR930012004A (ko) | 딜티아젬의 서방출성(徐放出性) 제형의 제조방법 | |
Hassanzadeh et al. | Fabrication and evaluation of release characteristics of polymeric films for transdermal | |
JPS6357530A (ja) | エイズ抗体治療薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20070112 Year of fee payment: 13 |
|
EXPY | Expiration of term |